Category: 1 Minute-Read

Categories
1 Minute-Read

IndiGo’s 10% cut barely trims flights

IndiGo’s planned 10% reduction in its winter schedule results in only a 2.35% drop in actual flights because the airline had not been using its full permitted capacity.

The DGCA had allowed IndiGo around 2,145 daily departures, but it consistently operated below 2,000 flights per day over the past year.

This means the mandated cut brings daily flights down only slightly, to about 1,931. Analysts estimate a revenue impact of ₹1,200–1,400 crore, or roughly 1.3–1.7% of annual earnings.

Overall, the headline cut appears steep, but its operational impact around IndiGo is limited.

Categories
1 Minute-Read

Aequs shares listed at 13% premium on day 1

Aequs’ shares debuted on the stock market on Dec 10 at ₹396, marking a 13% premium over its IPO price of ₹350.

Despite this positive listing, the stock fell short of grey market expectations, which had predicted a higher premium. The company’s IPO had garnered strong investor interest, being subscribed multiple times.

Aequs, an aerospace and engineering services firm, aims to leverage this listing to strengthen its market presence and fund expansion plans, including scaling operations and exploring new business opportunities.Analysts noted that while the listing was encouraging, it highlighted a gap between market anticipation and actual investor response.

Categories
1 Minute-Read

ICICI Prudential AMC IPO opens December 12

India’s largest asset management company, ICICI Prudential AMC, is launching its IPO on December 12, 2025, with anchor bidding on December 11.

The ₹10,602.65 crore offer is fully structured as an offer-for-sale, with Prudential Corporation Holdings offloading up to 4.9 crore shares. The price band is set at ₹2,061–₹2,165 per share, with retail investors allowed a minimum investment of ₹12,990 (6 shares per lot).

Allotment is expected by December 17, and listing on BSE and NSE is tentatively scheduled for December 19. The IPO’s GMP is reported at ₹119 over the issue price.

Categories
1 Minute-Read

Corona Remedies IPO

The Corona Remedies IPO, priced between ₹1,008–₹1,062 per share, saw robust demand, closing Day 3 with a 32× overall subscription.

The Non-Institutional Investor (NII) segment led the frenzy, oversubscribed 107×, while retail and qualified institutional buyers also showed strong interest.

Grey Market Premium (GMP) surged to around ₹30 per share, indicating high listing expectations. The IPO, valued at ₹655 crore through an offer-for-sale, reflects strong market confidence.

Investors are keenly watching the listing, but experts advise caution given the steep oversubscription and potential volatility post-listing.

Categories
1 Minute-Read

Neochem Bio shares spike 10% on market debut

Neochem Bio Solutions made a strong start on the stock market on Tuesday. Its shares opened at ₹108 each, marking a 10.2% premium over the IPO price of ₹98. The stock later rose to ₹111.20, giving early investors quick gains.

The company raised ₹44.97 crore through its IPO, issuing 45.88 lakh new shares. Funds from the IPO will be used for working capital, repaying borrowings, and general corporate purposes.

The IPO was highly subscribed, with overall demand 15.5 times the issue size. Qualified institutional buyers applied for 21.97 times, non-institutional investors for 21.15 times, and retail investors for 9.42 times of the shares offered.

Neochem Bio Solutions produces specialty performance chemicals for industries like textiles, home and personal care, water treatment, paints, construction, and more, with a portfolio of over 350 chemical formulations.

Categories
1 Minute-Read

Meesho IPO allotment done, listing on Dec 10

Meesho has completed the allotment for its IPO, which attracted strong investor interest. The issue was subscribed nearly 79 times, showing heavy demand from retail and institutional investors.

In the grey market, the stock was trading at a premium of around ₹40–₹45 per share over the issue price of ₹111, indicating an expected listing price of around ₹150–₹155.

Refunds for non-allottees began from 9 December, while shares were credited to demat accounts the same day. The stock is scheduled to list on the exchanges on 10 December, as Meesho targets growth in tech and logistics.

Categories
1 Minute-Read

Trump approves Nvidia H200 AI chip sales to China

The US government, under former President Donald Trump, has cleared Nvidia to sell its powerful H200 AI chips to selected customers in China. These chips, designed for artificial intelligence and large-scale computing, were previously restricted from export due to security concerns.

As part of the approval, the US will receive 25% of the sales revenue. Nvidia welcomed the decision, saying it supports American manufacturing and jobs while maintaining safeguards. Investors responded positively, and experts note the move could accelerate Chinese AI development while benefiting the US economically.

Categories
1 Minute-Read

Mahindra & Mahindra shares rise on 18% production jump

Mahindra & Mahindra reported strong performance in November, with vehicle production rising over 18% year-on-year.

The company’s total sales grew by nearly 20%, reflecting steady demand across key segments. Passenger vehicle sales rose sharply, while commercial vehicle sales also showed healthy growth.

Tractor sales recorded a major jump, driven by improved rural demand. Exports increased as well, supporting overall growth. The strong performance boosted investor confidence, leading to gains in the company’s share price.

The results highlight Mahindra’s growing market strength and improving production efficiency.

Categories
1 Minute-Read

Snapdeal parent AceVector files ₹300 crore IPO papers

AceVector, the parent company of Snapdeal, has filed an updated Draft Red Herring Prospectus with SEBI, moving closer to its IPO launch.

The offer includes a ₹300 crore fresh issue of equity shares, alongside an Offer-for-Sale of about 63.8 million shares by existing investors.
Promoted by founders and backed by SoftBank, Nexus Venture Partners, eBay, and Temasek, AceVector also operates Unicommerce and Stellaro Brands.

Proceeds from the IPO are planned for marketing, technology upgrades, and strategic growth initiatives. The filing signals the company’s intent to strengthen its financial position and expand in India’s competitive e‑commerce market.

Categories
1 Minute-Read

Meesho IPO allotment for ₹5,421 cr closes this week

The Meesho IPO allotment will be finalised on 8 December 2025, with refunds and share credits expected by 9 December.

Investors can check their allotment status via registrar Kfin Technologies or the BSE and NSE websites. The ₹5,421 crore IPO saw overwhelming response, being oversubscribed nearly 79 times, reflecting strong demand from both retail and institutional investors.

Grey-market trends indicate a premium of ₹40–₹43, hinting at a potential listing price of ₹150–₹153. Analysts say the strong subscription and GMP signal positive investor sentiment, setting the stage for a promising debut on the stock exchanges.